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Abstract
PMEL is an amyloidogenic protein that appears to be exclusively expressed in pigment cells and forms intralumenal fibrils
within early stage melanosomes upon which eumelanins deposit in later stages. PMEL is well conserved among vertebrates,
and allelic variants in several species are associated with reduced levels of eumelanin in epidermal tissues. However, in most
of these cases it is not clear whether the allelic variants reflect gain-of-function or loss-of-function, and no complete PMEL
loss-of-function has been reported in a mammal. Here, we have created a mouse line in which the Pmel gene has been
inactivated (Pmel
2/2). These mice are fully viable, fertile, and display no obvious developmental defects. Melanosomes
within Pmel
2/2 melanocytes are spherical in contrast to the oblong shape present in wild-type animals. This feature was
documented in primary cultures of skin-derived melanocytes as well as in retinal pigment epithelium cells and in uveal
melanocytes. Inactivation of Pmel has only a mild effect on the coat color phenotype in four different genetic backgrounds,
with the clearest effect in mice also carrying the brown/Tyrp1 mutation. This phenotype, which is similar to that observed
with the spontaneous silver mutation in mice, strongly suggests that other previously described alleles in vertebrates with
more striking effects on pigmentation are dominant-negative mutations. Despite a mild effect on visible pigmentation,
inactivation of Pmel led to a substantial reduction in eumelanin content in hair, which demonstrates that PMEL has a critical
role for maintaining efficient epidermal pigmentation.
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Introduction
Vertebrates produce two types of pigment - red/yellow
pheomelanins and black/brown eumelanins [1]. Premelanosome
protein (PMEL also known as PMEL17, SILV or gp100) is an
integral membrane protein exclusively expressed in pigment cells
that synthesize primarily eumelanins [2]. In mouse, PMEL
expression starts at E9.5 in the presumptive retinal pigment
epithelium (RPE) and at E10.5 in neural crest-derived melano-
blasts, suggesting a function in the early stages of melanosome
biogenesis [3]. Several studies have shown that fragments derived
from proteolytic maturation of PMEL form the fibrillar matrix
within melanosomes upon which eumelanins are ultimately
deposited [4]. A role for PMEL fibrils in melanosome maturation
is suggested by their ability to template and accelerate polymer-
ization of highly reactive eumelanin precursors [5–7]. The
presence of PMEL has therefore been assumed to be critical for
the normal production or stabilization of eumelanin but not
pheomelanin. Fibrils formed by PMEL in vitro have biophysical
hallmarks of amyloid such as those formed in Alzheimer’s and
Parkinson’s diseases [6], providing a model for functional/non-
pathological amyloid formation [8].
PMEL is well conserved among vertebrates and thus must play
an important physiological role; the average amino acid sequence
identity for PMEL among distantly related mammalian species
(mouse-human) is in the range 75–80% (Table S1) and is as high
as 50% between humans and zebrafish within certain subdomains
[4]. Indeed, PMEL mutations resulting in hypopigmentation have
been identified in a number of vertebrate species. The first
reported mutation affecting PMEL function showed that the
recessive silver allele in mouse (Pmel
si) is caused by a single
nucleotide insertion that truncates the last 25 C-terminal residues
of PMEL within the cytoplasmic domain [9,10]. This results in
intracellular transport defects that deplete PMEL from early stage
PLoS Genetics | www.plosgenetics.org 1 September 2011 | Volume 7 | Issue 9 | e1002285melanosomes [11]. Based on this mutation, the gene encoding
PMEL was named Silver but has recently been renamed Pmel to
provide a consistent nomenclature across species; the human
homolog is named PMEL accordingly. The silver allele dilutes
black/brown eumelanin but has no observable effect on
pheomelanin and causes hair graying over time on black
backgrounds [12,13]. Microscopic examination of hairs revealed
that some have no pigment at all, others had a reduced number of
scattered pigment granules, while some were white with sparsely
pigmented areas [12]. The graying phenotype was more
pronounced in silver mice with mutations at the Tyrosinase-related
protein 1 locus (Tyrp1 or B), indicating a gene interaction between
Pmel and Tyrp1 [13,14]. Surprisingly the graying seemed to
decrease with age in agouti mice, as opposed to the progressive
graying on black backgrounds [12]. Relative to the elongated
melanosomes in eumelanin-producing melanocytes from wild-type
mice, melanosomes in immortalized melanocytes derived from
silver mice are larger and round when analyzed by electron
microscopy [11].
Mutations in Pmel homologs causing pigmentation phenotypes
within a number of species have now been identified. In the
domesticated chicken, a three amino acid insertion in the
transmembrane (TM) region is associated with the Dominant
white phenotype, inhibiting the production of all eumelanin in
plumage, skin and uveal melanocytes in the choroid layer of the
eye, whereas the RPE is not affected [15,16]. Earlier studies
showed that Dominant white was associated with irregularly
shaped and assembled melanosomes [17] and pigment cell death
[18]. In fact, Brumbaugh and Lee [19] suggested already 1975 on
the basis of ultrastructural studies that Dominant white encodes a
structural component involved in premelanosome formation
which has now been confirmed by the identification of PMEL as
the associated gene product. A five-amino acid deletion in the TM
region and a point mutation downstream of the TM are associated
with the Dun allele which has a similar effect on pigmentation as
Dominant white [16]. The Smoky plumage color phenotype arose in
a flock of Dominant white birds where pigmentation is partially
restored due to a four amino acid deletion in the Polycystic Kidney
Disease repeat domain [16], a lumenal region thought to be
partially responsible for both PMEL localization [20] and fibril
formation [21]. In horses, a missense mutation in the cytoplasmic
region of PMEL is associated with dilution of black pigment in the
mane and tail [22]. The zebrafish mutant fading vision (fdv) exhibits
hypopigmentation in RPE and body melanocytes and a defect in
vision, and is caused by a premature stop codon [23]. The Merle
coat color pattern in dogs, characterized by patches of diluted
pigment, is associated with the insertion of a short interspersed
element (SINE) in intron 10 and the affected merle dogs exhibit
auditory and ophthalmologic abnormalities resembling human
patients with Waardenburg syndrome [24]. In cattle, a coat color
dilution phenotype is associated with a missense mutation G22R in
the signal peptide of PMEL, but conclusive evidence that this is the
causative mutation has not yet been reported [25]. Importantly, in
none of these cases is it clear that the mutation is a complete loss of
PMEL function.
Mutations in genes important for coat pigmentation in
laboratory mice are easily detected in mutagenesis screens and
to date, 169 genes affecting pigmentation have been identified [26]
(URL: http://www.espcr.org/micemut). In some of these genes,
hundreds of mutations have been reported; for example, 104
alleles have been identified in the Tyrosinase (Tyr) gene, most of
them causing albinism [27]. It is therefore somewhat surprising
that only one Pmel mutation has been identified in mice as PMEL
evidently has an important role in the melanocyte. This indicates
that either (i) PMEL has other yet unknown functions and that
inactivating mutations are embryonically lethal, or (ii) that
complete loss-of-function mutations at the Pmel locus have no or
only mild visible effects on pigmentation that are not readily
detected in mouse mutagenesis screens.
To address the role of a non-functional PMEL in vivo, we have
generated a knockout mouse line. In this study, we report that
mice homozygous for the inactivated Pmel allele on black
backgrounds have spherical melanosomes and display a weak
dilution of eumelanin, similar to the one present in Pmel
si mice.
The data show that inactivation of PMEL does not dramatically
disrupt pigmentation in vivo, and that mutations in Pmel homologs
that render a loss of pigmentation therefore possess dominant-
negative activity. The latter is demonstrated in an accompanying
paper showing that the Dominant white allele in chicken, as well as
the Silver allele in horses, encode pathogenic forms of the PMEL
amyloid [28].
Results
Generation and validation of Pmel knockout mice
To generate a knockout construct, we prepared a pFlrt3-vector
that included a fragment spanning exon 2 to exon 3 of the Pmel
gene flanked by loxP sites and a neomycin selection cassette
flanked by FRT sites (Figure 1A). The target construct was
introduced into R1 ES-cells by electroporation and gene targeting
was confirmed by long range PCR (data not shown) and Southern
blot analysis (Figure 1B), in which the targeted gene generates a
novel 7.7 kb band. Positive ES-cell clones were injected into
blastocysts, which subsequently were implanted into female foster
mice. Chimeric male offspring were bred to C57BL/6J mice and
their offspring carrying the targeted Pmel allele were subsequently
bred to PGK-Cre transgenic mice (C57BL/6J), in which Cre is
driven by the ubiquitously expressed PGK promoter [29], to
generate Pmel
+/2 offspring. The Pmel
+/2 mice were further bred to
C57BL/6J for two subsequent generations, and Pmel
+/2 offspring
were then intercrossed to generate homozygous null offspring. The
loss of Pmel mRNA expression was confirmed by a qPCR test,
using cDNA synthesized from skin RNA, that showed about two-
fold reduction of the Pmel transcript in skin from Pmel
+/2 mice
relative to Pmel
+/+ mice as expected, and a 279-fold reduction of
the transcript level in Pmel
2/2 mice compared to Pmel
+/+
Author Summary
Pigmentation has since long constituted a prime model to
study how genes act and interact. The PMEL gene encodes
a protein exclusively found in the melanosomes of
pigment-producing cells. Mutations in PMEL underlie
some spectacular color phenotypes in animals including
Dominant white color in chickens, Silver in horses, and
Merle in dogs, but no spontaneous mutation causing a
complete inactivation of this gene has yet been found in
mammals. We have now developed a PMEL knockout
mouse to further study the function of this protein. We
show that mice lacking PMEL have almost normal visible
pigmentation. However, loss of PMEL has a dramatic effect
on the morphology of the melanosomes in skin, hair, and
eye, such that the normally rod-shaped melanosomes in
wild-type animals are spherical in the knockout mice. The
knockout animals also have a substantial reduction in the
content of black pigment in hair. The study establishes
that PMEL has a critical role for maintaining normal
pigment production.
Pmel
2/2 Mice Have Eumelanosomes with Altered Shape
PLoS Genetics | www.plosgenetics.org 2 September 2011 | Volume 7 | Issue 9 | e1002285Figure 1. Strategy for the generation and validation of Pmel
2/2 mice. (A) Schematic representation of the Pmel
+, Pmel
loxP, and Pmel
2 alleles.
The exons (gray boxes), primers used for genotyping (black arrowheads), KpnI restriction cleavage sites and the target site of Southern blot probe (SP,
black box) are all indicated. In the Pmel
loxP allele, exon 2 and exon 3 are loxP-flanked (red circles) and a neomycin (green box) gene is flanked by two
FRT-sites (blue boxes). In the Pmel
2 allele, exon 2 and exon 3 are deleted after Cre-recombinase induced homologous recombination between the
loxP sites. (B) Southern blot showing targeted and control ES-cells. The wild-type and the Pmel
loxP alleles generate a 9.7 kb band and a 7.7 kb band,
respectively. (C) Pmel mRNA expression. A 1.9-fold change was detected in skin tissue when homozygous Pmel
+/+ mice were compared to Pmel
+/2
heterozygotes. A 279-fold change was detected when homozygous Pmel
2/2 mice were compared to homozygous wild-type mice. (D) Western blot
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detection limit by this assay, suggesting that Pmel
2/2 mice lack
Pmel expression.
Primary cultures of skin-derived melanocytes were established
from neonatal wild-type C57BL/6 and Pmel
2/2 mice. Immuno-
blotting analyses with a panel of three PMEL antibodies showed
that PMEL protein was readily detected in whole cell lysates of
wild-type melanocytes (mel Pmel
+/+) but absent from lysates of
Pmel
2/2 melanocytes (mel Pmel
2/2) (Figure 1D, upper panels).
Lysates from transfected HeLa cells expressing human PMEL
(HeLa hPMEL) or untransfected human fibroblasts (Fibrobl) were
used as positive and negative controls, respectively. By contrast,
two melanocyte-specific proteins, tyrosinase (TYR) and tyrosinase-
related protein 1 (TYRP1), and a house-keeping protein, c-
tubulin, were expressed at similar levels in wild-type and Pmel
2/2
melanocytes (Figure 1D, lower panels). Thus we conclude that our
construct effectively inactivated the expression of PMEL in skin-
derived melanocytes, but did not affect the expression of other
melanogenic proteins.
Inactivation of Pmel does not disrupt pigment synthesis
but alters the shape of melanosomes
To assess the requirement for PMEL in pigmentation and
melanosome distribution, primary cultures of skin-derived mela-
nocytes from wild-type C57BL/6 and Pmel
2/2 mice were
analyzed by bright-field microscopy (Figure 2A). No obvious
alteration in the degree of pigmentation could be observed in
Pmel
2/2 primary melanocytes compared to the wild-type by this
analysis. To better appreciate the effect of the loss of PMEL on
melanosome ultrastructure, primary melanocytes from Pmel
+/+
and Pmel
2/2 mice were analyzed by electron microscopy. This
analysis demonstrated that the loss of PMEL causes an altered
shape of melanosomes (Figure 2B). Melanosomes in wild-type mice
are rod-shaped; thus, in thin sections in which the rod-shaped
structures are sectioned in random planes, the melanosomes
appeared as a mixture of ellipsoids (transverse sections) and
spheres (cross-section; Figure 2B). By contrast, melanosomes in
Pmel
2/2 mice were always spherical, suggesting that they were no
longer rod-shaped (Figure 2B). To quantify this effect, we
measured the diameters of melanosomes along the long (length)
and short (width) axes (Figure 2C). There was a weak correlation
between the length and width of melanosomes in wild-type
homozygotes (r=0.52), consistent with their ellipsoidal shape,
whereas in the knockout mice, the width and length of
melanosomes were strongly correlated (r=0.93), consistent with
a spherical shape. Together, these data show that PMEL is not
required for pigment production per se, but is necessary for the
normal ellipsoidal shape of melanosomes.
The electron microscopy analysis revealed a number of
additional features of melanosome architecture that were altered
in Pmel
2/2 melanocytes relative to wild-type cells. First, whereas
fibrillar stage II and III melanosomes were readily identified
within wild-type melanocytes, no fibrillar intermediates were
detected in Pmel
2/2 melanocytes although endosomal organelles
were clearly visible (Figure 2B, compare Figure 2Bb and
Figure 2Bd). This was expected given the previously established
role for PMEL as the structural foundation for the fibrils. Second,
many of the melanosomes in Pmel
2/2 melanocytes were associated
with dense, granular deposits of melanin rather than the smooth,
fibrillar deposits observed in wild-type melanocytes (Figure 2Bd).
Together, these data suggest that PMEL is also required for the
normal polymerization of melanin, with potential adverse
consequences for melanosome integrity.
PMEL is not required for melanosome maturation or
segregation from late endosomes/lysosomes
PMEL fibrils in wild-type melanocytes begin to form in stage I
melanosomes, which mature into stage II melanosomes by fibril
assembly and into stage III/IV melanosomes following the
delivery of membrane-bound melanosome cargoes and conse-
quent melanogenesis [30,31]. However, stage I melanosomes are
also accessible to endocytic cargo and appear to be intermediates
in the maturation of late endosomes and lysosomes, which are
separate from later stage melanosomes [31]. We therefore
investigated the possibility that PMEL is required for the normal
development of melanosomes and the segregation of cargoes
destined for late stage melanosomes from those destined for late
endosomes/ lysosomes. Primary melanocytes from wild-type
C57BL/6 and Pmel
2/2 mice were analyzed by immunofluores-
cence and bright field microscopy for markers of melanosomes and
late endosomes/ lysosomes (Figure 3). As expected, Pmel
2/2
melanocytes lacked labeling for the PMEL-specific antibody
HMB45 (Figure 3Aa, d) but were robustly labeled for TYRP1
(Figure 3Ab, e). Importantly, labeling for TYRP1 predominantly
surrounded pigment granules in both wild-type and Pmel
2/2
melanocytes (Figure 3Ac, f and insets). Furthermore, both TYRP1
and pigment granules showed only minimal overlap with LAMP2,
a marker specific for late endosomes/ lysosomes (Figure 3B; note
insets in panels c, f). These data demonstrate that PMEL is not
required for either melanosome maturation or for the segregation
of melanosomes from late endocytic compartments.
PMEL expression and function in skin, eye, and inner ear
We investigated whether the inactivation of PMEL expression
caused changes in morphology or pigmentation in skin, eye, and
inner ear. Skin from Pmel
+/+ mice had pigmented cells in hair
follicles that were immunoreactive for PMEL using the Pep13h
antiserum (Figure 4Aa, b). The Pep13h antiserum detects the
cytoplasmic domain only found on immature PMEL forms in
early secretory organelles and the immunoreactivity thus reflects
the site of PMEL synthesis [32]. Only background Pep13h-
immunoreactivity was seen on pigmented cells in hair follicles in
skin from the Pmel
2/2 mice (Figure 4Ac, d). The melanocytes in
the knockout mice were intact and had pigmentation, thus PMEL
is not required for pigmentation of melanocytes in situ.
Comparison of the choroid and outer layers of the retina in 3
day postnatal and 18-months old Pmel
+/+ and Pmel
2/2 mice,
showed that the choroidal melanocytes and RPE cells were
analysis. Whole cell lysates from primary cultures of skin-derived melanocytes from wild-type (mel Pmel
+/+)o rPmel
2/2 (mel Pmel
2/2) C57BL/6 mice
were used, and lysates from transfected HeLa cells expressing human PMEL (HeLa hPMEL) or untransfected human fibroblasts (Fibrobl) were used as
positive and negative controls. The lysates were fractionated by SDS-PAGE and analyzed by immunoblotting with a panel of antibodies directed
against PMEL (amPmel-N, HMB45, and aPep13h) or the control proteins, tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), and c-tubulin.
amPmel-N recognizes an N-terminal peptide from mouse PMEL; HMB45 recognizes an epitope derived from the central region of PMEL that is
enriched on fibrils; and aPep13h detects the PMEL C-terminus. Migration of molecular weight markers (in kDa) is shown to the left, and relevant
bands are indicated to the right.
doi:10.1371/journal.pgen.1002285.g001
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+/+)
and Pmel
2/2 mice. (A) Bright-field microscopy; scale bar, 20mm; inset, 5X magnification. Note that the distribution of melanosomes is similar in both
sets of melanocytes. (B) Electron microscopy. Cross-sections of melanosomes in the Pmel
+/+ melanocytes are both spherical and rod shaped, whilst
they are only spherical in the Pmel
2/2 melanocytes. I, II, III, and IV represent stage I, II, III, and IV melanosomes. M, mitochondria; End, endosomes.
Note the presence of fibrillar stage II and III melanosomes in the wild-type melanocytes (panel Bb, marked with arrowheads in inset) in contrast to the
granular deposits of melanin in Pmel
2/2 melanosomes (panel Bd, marked with arrows in inset). Bars: 500 nm and 200 nm, in left and right panels
respectively (C) Plot of the diameters of melanosomes along the long (length) and short (width) axes measured from electron microscopy images;
n.200 for both genotypes. There was a weak correlation between the length and width of melanosomes in Pmel
+/+ cells (r=0.52), consistent with
their ellipsoidal shape, whereas in Pmel
2/2 cells, there was a strong correlation (r=0.93), indicating a spherical shape. The difference in the length/
width ratio between wild-type and Pmel
2/2 is overwhelmingly significant (Analysis of variance; F=161, d.f.1=1, d.f.2=451; P,10
26).
doi:10.1371/journal.pgen.1002285.g002
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(Figure 4B). Weak Pep13h-staining in the RPE of Pmel
2/2 mice
was also seen in the secondary antibody-controls in both wild-type
and knockout retinas, and thus represented background immuno-
reactivity likely due to the well-established non-specific binding to
Bruch’s membrane. Western blot analysis of retina from wild-type
Figure 3. Immunofluorescence and bright field microscopy of primary melanocytes from C57BL/6 wild-type (Pmel
+/+) and knockout
(Pmel
2/2) mice. (A) Cells immunolabeled with antibodies against the mature PMEL protein (HMB45, red; a, d, insets) and TYRP1 (green; b, e, insets);
the melanosomes were visualized by bright field (c, f) and pseudo-colored blue in the insets. Note the presence of TYRP1 surrounding melanosomes
in both sets of melanocytes. (B) Cells immunolabeled with antibodies against the late endosome/ lysosome marker LAMP2 (green; b, e, insets) and
TYRP1 (red; a, d, insets); the melanosomes were visualized by bright field (c, f) and pseudo-colored blue in the insets. Note the segregation of LAMP2
labeling from pigment granules labeled by TYRP1. Size bar, 20 mm.
doi:10.1371/journal.pgen.1002285.g003
Pmel
2/2 Mice Have Eumelanosomes with Altered Shape
PLoS Genetics | www.plosgenetics.org 6 September 2011 | Volume 7 | Issue 9 | e1002285and knockout mice using the Pep13h-antiserum confirmed the
absence of PMEL in the eyes from the Pmel
2/2 mice (Figure S1).
To test whether melanosome shape was altered in eye pigment
cells as in skin melanocytes, we analyzed thin sections of the retina
by electron microscopy. Whereas melanosomes in the uveal
melanocytes of the choroid layer and particularly in the RPE cells
of wild-type mice were oblong, the melanosomes in both cell types
in the Pmel
2/2 mice were spherical (Figure 5), in perfect
agreement with the results obtained by electron microscopy of
primary skin-derived melanocytes. Moreover, as in Pmel
2/2 skin
melanocytes, many of the melanosomes in Pmel
2/2 RPE showed
irregular melanin aggregates and poorly preserved membranes
(Figure 5D). This demonstrates that PMEL is required for normal
development of the melanosomes in all three cell types (skin
melanocytes, choroid melanocytes, and RPE cells).
The striking changes in the structure of the RPE melanosomes
suggested that the Pmel
2/2 mice might have alterations in retinal
integrity that might impair their vision. To test this hypothesis,
we performed electroretinography (ERG) on two 18-month old
Pmel
2/2 mice and two age-matched controls. The results showed
that amplitudes, implicit times, and waveforms for both dark-
adapted and light-adapted responses were similar between
Pmel
2/2 and Pmel
+/+ mice. Hence, the results showed that
despite the changes in melanosome architecture, loss of PMEL
expression did not cause a severe impairment of retinal function
detectable with full-field ERG.
To test whether loss of PMEL expression affects the morphology
of the inner ear, thin sections of cochlear samples dissected from
the inner ears of two Pmel
2/2 mice and one wild-type mouse were
analyzed by electron microscopy (Figure S2). All cells, including
Figure 4. Immunohistochemistry of skin and retina from Pmel
+/+and Pmel
2/2 mice. Sections of skin (A) or retina (B, C) from Pmel
+/+ (a, b)
and Pmel
2/2 (c, d) mice were immunolabeled with aPep13h (anti-PMEL) (A, B) or secondary antibody alone (C) and counterstained with DAPI to label
nuclei, and analyzed by immunofluorescence microscopy (a, c) or bright field microscopy to assess pigmentation (b, d). (A) PMEL-immunoreactive
cells were found in the hair follicles of the skin in wild-type mice (a–b), but not in the Pmel
2/2 mice (c–d). Insets, two-fold enlargement of the boxed
region. (B) aPep13h immunoreactive cells (green) were found in the choroid (arrowheads) and in the RPE from the Pmel
+/+ mouse (a), but only in the
RPE/ Bruch’s membrane from the Pmel
2/2 mouse (c). GCL, ganglion cell layer. (C) Immunostaining obtained using only the secondary anti-rabbit
antibody shows a signal from Bruch’s membrane. Size bar, 20 mm.
doi:10.1371/journal.pgen.1002285.g004
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there was no obvious difference in overall morphology between
the two genotypes. Furthermore, the knockout mice had normal
Preyer reflexes, a rough physiological indication of ‘‘normal’’
hearing.
Loss of PMEL affects coat and skin pigmentation in a
qualitatively subtle but quantitatively substantial manner
The Pmel
2/2 mice are fully viable, fertile, and display no
obvious developmental defects. Furthermore, Pmel
2/2 mice on a
C57BL/6 background – which have the genotype Asip
a/a at the
Figure 5. Electron microscopy of choroidal (upper and lower left micrographs) and RPE cells (upper and lower right micrographs),
including melanosomes, from wild-type C57BL/6 mice (upper two micrographs) and Pmel
2/2 mice (lower two micrographs),
respectively. A scale bar is depicted in the lower left hand corner of each micrograph. Melanosomes of both choroidal and RPE cells of the affected
animal appear spherical with irregular borders, the latter more obvious in the RPE cells (lower right micrographs, indicated by white arrowheads).
Further, no cigar-shaped melanosomes were found in either choroidal or RPE cells in the Pmel
2/2 mice.
doi:10.1371/journal.pgen.1002285.g005
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eumelanin – did not display striking hypopigmentation. We
therefore tested the effect of the Pmel
- mutation on coat color
dilution in different genetic backgrounds by intercrossing our
C57BL/6 Pmel
2/2 line with BALB/c mice for three generations.
In addition to segregating the Pmel locus, this intercross segregated
three additional coat color loci: agouti-signaling protein (Asip), the
classical Agouti (A) locus; tyrosinase-related protein 1 (Tyrp1), the
classical Brown (B) locus; and Tyrosinase (Tyr), the classical Albino
(C) locus. The genotypes at these four loci in the parental lines of
the intercross were Pmel
2/2, Asip
a/a, Tyrp1
B/B, Tyr
C/C for the
C57BL/6 line and Pmel
+/+, Asip
A/A, Tyrp1
b/b, Tyr
c/c for Balb/c
(lower case letters represent the recessive allele at each locus). The
Pmel knockout showed a subtle effect on black (Asip
a/a, Tyrp1
B/B;
Figure 6a), brown (Asip
a/a, Tyrp1
b/b; Figure 6b), agouti (Asip
A/A,
Tyrp1
B/B; Figure 6c), and brown agouti (Asip
A/A, Tyrp1
b/b;
Figure 6d) backgrounds. On a black background, a weak silvering
effect in the coat color was seen, and the pigmentation on the paws
and tail was reduced (Figure 6e, f), suggesting perhaps a more
pronounced effect on pigmentation in interfollicular epidermis and
dermis. The most pronounced effect of the Pmel knockout was
observed on the brown background, where the brown pigmenta-
tion was markedly diluted. Brown agouti, Pmel
2/2 mice had an
apparent dilution of the dark hairs, whilst the yellow pigmentation
seemed unaffected. A more subtle effect of the Pmel
2/2 genotype
was noted in agouti mice, but their paler tails distinguished the
knockouts from the wild-type littermates. Together, these data
confirm a previously described genetic interaction between the
Pmel silver (Pmel
si/si) allele with the brown (Tyrp1) locus [13,14].
However, a difference was that the previous studies indicated that
silver showed a more pronounced effect in Tyrp1 heterozygotes
whereas we only observed an altered pigmentation in Tyrp1
b/b
homozygotes. The results of this cross-breeding experiment show
that PMEL only modestly influences visible pigmentation in hair
and skin.
The effect of inactivating Pmel on pigment production was also
assessed quantitatively by a chemical analysis using previously
described methods [33–36]. A comparison of pigment content in
hair from wild-type and Pmel
2/2 mice on a C57BL/6 background
demonstrated that loss of PMEL expression causes a substantial
reduction (244%) of eumelanin content (Table 1); no significant
effect on pheomelanin content was noted. This result was further
corroborated by analyzing melanin content in the eight animals
depicted in Figure 6. In each pairwise comparison on the same
genetic background, the knockout mouse showed a lower amount
of eumelanin in hair, ranging from 35–69% of the level observed
in wild-type hair (Table 2). The most pronounced reduction was
observed in animals on a Tyrp1
b/b background, consistent with the
Figure 6. Phenotypic effects on pigmentation of the Pmel
2/2 genotype on four different genetic backgrounds. Coat color was assessed
in different genetic backgrounds by pairwise comparisons from an F2 intercross generation. Within each pair, the Pmel
2/2 and Pmel
+/+ mice are to the
left and right, respectively. (a) The non-agouti black (Asip
a/a) Pmel
2/2 mice displayed a subtle dilution of coat color and tail skin. (b) PMEL inactivation
in brown mice (Asip
a/a Tyrp1
b/b) caused the most dramatic reduction in coat color and tail skin pigmentation. (c) The black hairs of the Pmel
2/2 mice
on brown agouti (Asip
A/2 Tyrp1
b/b) background was diluted giving the coat a more yellow/light brown appearance compared to the wild-type. (d) The
weakest phenotypic effect associated with the Pmel
2/2 genotype was seen in agouti mice (Asip
A/2) but the coat and skin color were slightly lighter
relative to the wild-type. (e, f) The skin of the feet of non-agouti black (Asip
a/a) Pmel
2/2 mice were less pigmented compared to the wild-type.
doi:10.1371/journal.pgen.1002285.g006
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pheomelanin-content was noted among Pmel genotypes; by
comparison, homozygosity for the non-agouti allele at the Asip locus
caused a drastic reduction in pheomelanin content (Table 2).
The allele frequency distribution at the human PMEL
locus is consistent with purifying selection
Given the reduced hair and skin pigmentation in Europeans it is
conceivable that PMEL loss-of-function mutations have been
tolerated or even under positive selection in this population. To
address this question we exploited the low coverage resequencing
data for 60 European, 59 African, and 60 Asian individuals that
have recently been released by the 1000 Genomes Project [37]. The
result clearly indicated that this is not the case and the data are
consistent with purifying selection acting on the human PMEL locus
(Table 3). In the European population only synonymous substitu-
tions were found. In total, seven SNPs causing missense mutations
were found, most of them in Africa, but the minor allele frequency
at all loci were below 15%. Furthermore, in all three populations
synonymous SNPs showed the highest degree of genetic diversity, a
typical feature of a locus under purifying selection.
Discussion
The present study provides a substantial advance in under-
standing the role of PMEL and of the PMEL-derived amyloid
fibrillar melanosome matrix in pigment cell biology. The PMEL
protein has generally been thought to be important for
pigmentation since mutations in PMEL orthologs in several
species are associated with substantial pigment dilution, in some
cases attributable to poor melanocyte survival. This study
demonstrates that PMEL is essential for the normal development
of the rod-shaped melanosomes in eumelanin-producing melano-
cytes in hair, skin, and eye, but not for the general survival of
pigment cells in several tissues. Thus, while the amyloid fibrils
formed by proteolytic fragments of PMEL play a critical role in
generating the characteristic rod-shape of melanosomes, the Pmel
knockout mutation has a relatively mild effect on visible
pigmentation. A characteristic difference between melanosomes
in eumelanin- versus pheomelanin-producing melanocytes is the
shape of the melanosomes, rod-shaped versus spherical. The
present study demonstrates that the shape of the melanosomes is
not critical for which type of pigment is produced. Moreover,
despite a dramatic effect on melanosome shape and melanin
Table 1. Content of total melanin, eumelanin, and pheomelanin in wild-type and PMEL
2/2 mice on a C57BL/6 background (Asip
a/a).
PMEL genotype
Measure +/+ (n=3) 2/2 (n=4) t-test (d.f.=5) % of wild-type
A500/mg
a 0.90260.048 0.51860.045 10.8***
Total melanin (mg/mg)
a 91.1 52.3 57.4
PTCA (ng/mg)
b 45046177 25286168 15.1***
Eumelanin (mg/mg)
b 112.6 63.2 56.1
4-AHP (ng/mg)
c 27.061.7 31.562.6 22.5
Pheomelanin (mg/mg)
c 0.24 0.28 116.7
aAbsorbance at 500 nm, a measure of total melanin after Soluene-350 solubilization [34]. Total melanin content was estimated as A500/mg multiplied by a factor of 101.
bPyrrole-2,3,5-tricarboxylic acid (PTCA), a degradation product of eumelanin [33]. Eumelanin content was estimated by multiplying PTCA content by a factor of 25.
c4-Amino-3-hydroxyphenylalanine (4-AHP), a degradation product of pheomelanin. Pheomelanin content was estimated by multiplying 4-AHP by a factor of 9 [36].
doi:10.1371/journal.pgen.1002285.t001
Table 2. Eumelanin and pheomelanin content in wild-type and PMEL
2/2 mice on mice on different genetic backgrounds.
Genotype Phenotype
4-AHP
(ng/mg)
a
Pheomelanin
(mg/mg)
a
PTCA
(ng/mg)
b
Eumelanin
(mg/mg)
b
Eumelanin compared
with wild-type
(Pmel Asip Tyrp1)
+/+ a/a B/B black 7.0 0.06 3087 77.2
2/2 a/a B/B 27.1 0.24 2126 53.2 68.9%
+/+ a/a b/b brown 42.4 0.38 1222 30.6
2/2 a/a b/b 35.0 0.32 620 15.5 50.7%
+/+ A/2 B/B agouti 291 2.62 2635 65.9
2/2 A/2 B/B 248 2.23 1491 37.3 56.6%
+/+ A/2 b/b brown agouti 414 3.73 985 24.6
2/2 A/2 b/b 545 4.91 348 8.7 35.3%
The animals depicted in Figure 6 were analyzed.
a4-Amino-3-hydroxyphenylalanine (4-AHP), a degradation product of pheomelanin. Pheomelanin content was estimated by multiplying 4-AHP by a factor of 9 [36].
Based on a single determination per animal.
bPyrrole-2,3,5-tricarboxylic acid (PTCA), a degradation product of eumelanin [33]. Eumelanin content was estimated by multiplying PTCA content by a factor of 25. Based
on duplicate assays from a single animal/genotype.
doi:10.1371/journal.pgen.1002285.t002
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2/2
mice is not substantially impaired. Nonetheless, PMEL is well
conserved throughout vertebrate evolution, and we show the
presence of purifying selection at the human PMEL locus. Given
that our results support pigment cell-specific expression of PMEL,
this suggests that PMEL performs an essential function in pigment
cells.
This study provides a potential explanation why PMEL function
is well conserved among vertebrates. Despite only a subtle effect of
Pmel inactivation on visible pigmentation, we show a 40–50%
reduction in eumelanin content in hair from Pmel knockout mice
relative to controls. This demonstrates a substantially reduced
efficiency in pigmentation, implying that PMEL likely has an
essential function in vertebrates exposed to damaging UV light.
This function might reflect a role for PMEL in making pigment
production more effective by evenly distributing melanin poly-
merization throughout melanosomes. Such an enhancement of
pigment efficiency might be most critical in the RPE, in which
pigment formation is temporally limited to a brief pre- and post-
natal period and in which persistent interactions with phagolyso-
somes might expose poorly polymerized melanins to degradative
enzymes; indeed, a number of mutations in melanosome
biogenesis appear to more severely affect pigmentation in the
eye than in the skin [38]. Another possibility is that the
polymerization of eumelanins on PMEL fibrils facilitates melanin
transfer to keratinocytes, such that transfer is reduced in Pmel
2/2
skin.
The phenotype of the Pmel knockout mice is similar to the
silvering phenotype described for the mouse silver allele that arose
spontaneously [12–14] and that is caused by a premature stop
codon truncating the last 25 amino acid residues of PMEL [9,10].
This allele dilutes eumelanin pigmentation but has no clear effect
on pheomelanin pigmentation, consistent with the results in the
present study. Furthermore, a previous analysis of melanin content
showed that homozygosity for the silver allele caused a 20%
reduction in eumelanin content on a recessive black (Asip
a/a)
background and 40% reduction on a brown (Tyrp1
b/b) background
[39], in good agreement with the present results for Pmel
2/2 mice
(Table 1 and Table 2). The more pronounced effect of both
Pmel
si/si and Pmel
2/2 on eumelanin production on a brown
background might reflect a combined effect of TYRP1 on
tyrosinase stability [40,41], facilitating melanin formation, and of
PMEL on melanin polymerization/stability. However, a clear
difference between Pmel
si/si and Pmel
2/2 is that the silver allele
shows a more pronounced dilution of pigmentation on a
heterozygous brown background (Tyrp1
b/+) than on the homozy-
gous background (Tyrp1
b/b) [12–14], whereas we only observed a
phenotypic effect in the homozygous brown background. This
difference may be explained by the fact that the knockout is a null
allele, while silver encodes a truncated form of PMEL that lacks the
25 C-terminal amino acids from the cytoplasmic domain. The
silver PMEL variant is depleted but not absent from melanosomes
[11], and thus might confer partial function that in some way is
more deleterious in the presence of limiting amounts of functional
Tyrp1.
Consistent with the influence of PMEL primarily on eumelanin
accumulation shown here, the Dominant white allele in chickens [16]
and the Silver allele in horses [22] both show a dominant
inheritance and inhibit the production of eumelanin but have no
visible effect on pheomelanin. Surprisingly, the Dc allele in cattle
associated with a G22R missense mutation in PMEL is associated
with a dilution of both pheomelanin and eumelanin, but further
work is required to demonstrate the causative nature of the G22R
mutation [25].
Our results suggest that the alleles described in other species
with a more drastic effect on pigmentation, such as Silver in horses
[22], Merle in dogs [24], and Dominant white in chicken [16]
represent dominant negative mutations. The Dominant white and
Smoky alleles in chickens provide a good illustration [16]. Dominant
white inhibits the expression of black eumelanin and is caused by
an insertion of three amino acid residues in the transmembrane
domain. Smoky arose in a line homozygous for Dominant white and
restored pigmentation. The causative mutation for Smoky is a
deletion of four highly conserved residues in the PKD domain of
PMEL. Thus, a plausible interpretation of these data, in relation to
the phenotypic effects of the Pmel knockout mice, is that Dominant
white is a dominant negative mutation while the Smoky mutation is a
loss-of-function that inhibits the effect of Dominant white. Interest-
ingly, we have recently demonstrated that the Smoky mutation
indeed generates an essentially inactive form of PMEL, countering
a dominant gain-of-function by the Dominant white mutation [28].
The present study now provides a reasonable explanation why
only a single Pmel mutant has been described in mice compared
with the fairly high number of mutations at most other
pigmentation loci – that a Pmel loss-of-function has only a subtle
effect on visible pigmentation. By contrast, dominant PMEL
Table 3. Observed frequencies of the non-reference allele at the human PMEL locus on chromosome 12 in African (YRI), European
(CEU), and Asian (CHJPT) populations.
Nucleotide
position (bp) Nt change AA position AA change YRI CEU CHJPT
54,637,613 G/A 247 Synonymous 0 0.31 0.26
54,637,395 G/T 320 Pro/His 0 0 0.03
54,637,269 G/A 362 Ala/Val 0.01 0 0
54,637,267 G/A 363 Pro/Ser 0.04 0 0
54,637,244 C/G 370 Glu/Asp 0.06 0 0
54,637,014 G/A 447 Thr/Met 0.02 0 0
54,635,873 C/T 505 Gly/Ser 0.14 0 0
54,635,388 A/G 596 Val/Ala 0.14 0 0
54,634,295 G/A 652 Synonymous 0.53 0.84 0.84
Data generated by the 1000 genome project.
doi:10.1371/journal.pgen.1002285.t003
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study explains why dominant-negative mutations have been
selected in domestic animals without adverse pleiotropic effects
in other tissues, since we confirm that PMEL is a melanocyte-
specific protein. In this context, Merle dogs are unusual in having
pleiotropic defects. The phenotypic effects associated with Merle in
dogs is assumed to be caused by a retrotransposon insertion at the
boundary of intron 10/exon 11 of PMEL [24]. In the heterozygous
condition, Merle causes patches of diluted pigmentation and the
effect is restricted to the inhibition of eumelanin pigmentation
consistent with the effects of Pmel alleles in mice, chickens, and
horses. Merle homozygotes show very pale pigmentation associated
with hearing loss and visually defective microphtalmic eyes, and is
considered sublethal due to multiple abnormalities of the skeletal,
cardiac, and reproductive system [24,42]. Given our results that
loss of PMEL expression has only modest phenotypic effects, and
that PMEL appears to be a melanocyte-specific protein, the broad
phenotype observed in Merle dogs appears to be inconsistent with
a loss-of-function mutation that affects only PMEL expression.
There are several possible explanations for this enigma. Firstly,
there are not yet any published data showing that Merle is
associated with any altered expression of PMEL at the transcript
or protein level or that expression of a wild-type form of PMEL
can rescue the Merle phenotype. Thus, although it appears likely
that Merle is indeed a PMEL mutant because the effect on
pigmentation is restricted to eumelanin, as expected for a PMEL
mutant, it cannot be formally excluded that the non-pigment
effects of Merle reflect an additional mutation. However, the high
rate of germ-cell reversions [42] is consistent with a single
mutation caused by an insertion of a transposable element.
Secondly, the severe effects on hearing and vision in Merle
homozygotes compared with the apparently normal phenotype
observed in Pmel knockout mice might be explained if Merle was
the most severe dominant-negative mutation at the Pmel locus
detected so far. Thus it might result in extensive melanocyte death
in skin, eye, the inner ear, and even in the heart in which
melanocyte loss is associated with abnormalities [43]. A third
possible explanation for the pleiotropic effects on many different
tissues in Merle dogs is potential ectopic expression of PMEL
induced by the transposon insertion, and consequent toxic effects
of amyloid formation outside the melanosome. Finally, since
PMEL is located in a gene dense region (six genes within 100 kb) it
is possible that the Merle mutation alters the regulation of more
than one gene in the region. Thus, some of the phenotypic effects
of Merle may be associated with PMEL function whereas others
may be caused by altered expression of other closely linked genes.
An important justification for the development of knockout
mice models is to suggest possible pathological effects of
corresponding mutations in humans. The clear indication that
purifying selection acts at the human PMEL locus suggests that
loss-of-function mutations will cause reduced fitness. No human
PMEL mutation associated with any phenotypic effects or
disorders has yet been reported. Based on the results of the
present study and previously described spontaneous mutations we
can make the following predictions. Dominant-negative PMEL
mutations, like Dominant white in chicken and Silver in horses, are
expected to be associated with red hair and fair skin due to the
expected reduction of dark eumelanin. However, PMEL variants
do not appear to be a common cause of red hair and fair skin in
humans [44]. Loss-of-function mutations must exist in the human
population and no observable phenotypic effects are expected in
heterozygotes. Loss-of-function homozygotes are expected on the
basis of the phenotype of Pmel
2/2 mice to be fully viable but with a
reduced content of eumelanin pigmentation in skin and hair.
Thus, they are expected to be more sensitive to damaging UV-
light and have a higher risk to develop various forms of skin
cancer. PMEL has not been associated with an increased risk of
skin cancer in genome-wide association studies (GWAS) in
humans [45], but GWAS have a low power to identify rare
genetic variants as expected for PMEL loss-of-function mutations.
Our observation of an altered shape of the melanosomes both in
the RPE cells and in the uveal melanocytes of the eye suggests that
PMEL
2/2 humans may also show eye disorders, perhaps in
particular a higher incidence of age-related disorders such as
macular degeneration. The ERGs did not reveal a drastic effect on
retinal function, but since the sample size was small we cannot
exclude a subtle effect. Furthermore, visual impairment does not
always manifest in abnormal full-field ERGs. In this context it is
worth noting that the fading vision mutant at the PMEL locus in
zebrafish, in which a premature stop codon leads to production of
a truncated protein, causes a severe developmental defect of the
RPE and a consequent vision defect [23]. Furthermore, many
Silver horses show an eye disorder named Mutiple Congenital
Ocular Anomalities (MCOA) that resembles congenital aniridia in
humans [46,47]. Thus, the fact that three previously described
PMEL mutations - fading vision in zebrafish, Silver in horses and
Merle in dogs – are associated with different eye disorders and that
the melanosomes in pigment cells in the eye of Pmel
2/2 mice have
an altered shape clearly calls for further studies to explore if
changes in PMEL function may lead to impaired vision in
humans. The mouse model described here constitutes an excellent
resource for such studies.
Materials and Methods
Gene targeting and construct design
The strategy for building the targeting construct using the
pFlrt3-vector is shown in Figure 1A. A PCR-based strategy was
employed by using a proofreading enzyme (KOD Hot Start DNA
Polymerase, Novagen, USA). A pFlrt3-vector harboring two loxP
sites, two FRT sites, and a neomycin cassette was used. A 5.0-kb
upstream targeting arm starting in intron 1 (forward primer with
Cfr42I tail and reverse primer with NotI tail, Table S2) and a 2.4-
kb downstream targeting arm spanning from intron 3 to the
beginning of intron 6 (forward primer with Bsp119I tail and
reverse primer with XhoI tail, Table S2) were amplified. The 5.0-
kb fragment was cloned into the Cfr42I and NotI sites while the
2.4-kb fragment was cloned into the BstBI and XhoI sites in the
pFlrt3-vector. A 589 bp fragment spanning exon 2, intron 2, and
exon 3 (forward primer with BglII tail and reverse primer also with
BglII tail, Table S2) was cloned into the BglII site flanked by two
loxP-sites.
According to the Ensembl genome assembly available at the
time of the construct design, a knockout of the 589 bp fragment
would cause a frame-shift between exon 1 and exon 4 leading to a
premature stop codon and a non-functional PMEL protein.
However, during the process of generating our transgenic mice,
the Ensembl genome assembly was updated and the deletion of the
589 bp fragment turned out to cause an in-frame skipping of exon
2 and exon 3. Fortunately, the RNA was later shown to be
degraded and the PMEL protein absent in the knockout mice (see
Figure 1C and 1D).
The final target construct was linearized by XhoI and used for
homologous recombination in R1 ES cells [48]. 408 clones were
obtained and screened for homologous recombination by long
range PCR. In total, 30 clones were revealed as positive for a
targeting event. These were confirmed by Southern blot to be
positive, using a probe targeting upstream of the 5.0-kb fragment
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digested with the restriction enzyme KpnI and separated by 0.7%
agarose gel electrophoresis. Five clones were injected into
blastocysts taken from a cross between C57BL/6NCrl females
and B6D2F1/Crl males. The blastocysts were subsequently
implanted into CD1 females. Two chimeric mice (crossed with
C57BL/6J mice) were successfully used for germ line transmission.
The F1 agouti offspring were confirmed to be heterozygous at the
modified allele by PCR. F1 males were subsequently crossed with
C57BL/6J PGK-Cre females in order to generate animals
heterozygous for the null allele. After four generations of
backcrossing into a C57BL/6J background, heterozygous animals
were intercrossed to get homozygous null animals.
Genotyping of mutant mice
PCR amplification of genomic DNA extracted from tail biopsies
was performed to genotype mutant mice. Tail biopsies were
incubated 45 min in 96uC in lysis buffer (250 mM NaOH and
2 mM EDTA) and the reaction was inhibited by the addition of
400 mM TRIS HCl pH 8.0. The offspring of the chimeric mice
were genotyped for germline transmission using two primers
amplifying the wild-type and the targeted allele (primer A in intron
1 and primer B in the loxP-flanked fragment, Table S2). Primers A
and B generated a 236 bp band and a 392 bp band from the wild-
type and the targeted allele, respectively (Figure 1A). The offspring
of the PGK-Cre mice were genotyped to confirm the absence of
the loxP-flanked fragment using three primers amplifying the lox
and flox alleles (primers A, B, and D in the pFlrt3-vector flanked
by the loxP and FRT sites, Table S2). Primers A and B amplified
the floxed allele generating a 392 bp product, whilst no band was
produced from the knocked allele. Primers A and D amplifying the
floxed allele produced a 762 bp band and a 319 bp band was
produced from the knocked allele.
RNA isolation and qPCR analysis
RNA was isolated from skin tissue samples with the RNeasy
mini kit (Qiagen). The RNA samples were subjected to reverse
transcription using the cDNA high capacity kit (Applied
Biosystems). mRNA transcripts for the two alleles were measured
by quantitative PCR analysis using TaqMan Gene Expression
master mix (Applied Biosystems) on a 7900HT Fast RT-PCR
System (Applied Biosystems). Data were analyzed with a threshold
set in the linear range of amplification, based on a standard curve
of serial 10-fold dilutions for each primer set. The Pmel data were
normalized using two endogenous housekeeping genes (GAPDH
and 18S rRNA) and plotted as fold change.
Tissue preparation and immunohistochemistry
Whole eyes and skin were dissected and fixed in 4% PFA for
60 min, washed 10 min in PBS and cryoprotected in 30% sucrose
for 3 and 12 h, respectively, before being frozen in OCT (Sakura).
Tissues were cryosectioned (10 mm sections for eyes and 12 mm
sections for skin) and collected on Superfrost Plus glasses (Menzel-
Gla ¨ser). For immunohistochemistry, the sections were rehydrated
in PBS for 15 min and then blocked in PBS containing 1% fetal
calf serum, 0.02% thimerosal and 0.1% Triton X-100 for 30 min.
Primary and secondary antibodies were diluted in this solution.
Samples were incubated with primary antibodies overnight at 4uC,
and with secondary antibodies for 2 h at room temperature.
Samples were analyzed using a Zeiss Axioplan2 microscope,
equipped with Axiovision software. Images were formatted,
resized, enhanced and arranged for publication using Axiovision,
and Adobe Photoshop.
Antibodies
The following mouse monoclonal antibodies were used:
HMB45 to PMEL (Lab Vision, Fremont, CA); TA99/Mel5 to
TYRP1 (American Type Culture Collection, Manassas, VA; for
immunofluorescence microscopy); and GTU-88 to c-tubulin
(Sigma-Aldrich, St. Louis, MO). Polyclonal rabbit antibodies
included: H-90 to TYRP1 (Santa Cruz Biotechnologies, Santa
Cruz, CA; for immunoblotting); Pep7 [49] to tyrosinase,
ahPep13h [50] to the C-terminus of human PMEL, and
amPmel-N [11] to the N-terminus of mouse PMEL. Secondary
antibodies included FITC labelled anti-rabbit immunoglobulin (Ig)
antibodies (Vector laboratories) for immunofluorescence micros-
copy of eye tissues, or highly cross-absorbed goat or sheep
antibodies to mouse Ig, rat Ig, or isotype-specific antibodies to
mouse c1 and c2a heavy chains (Jackson Immunoresearch)
conjugated to Alexafluor 488 or Alexafluor 594 (InVitroGen).
Cell culture
Primary cultures of skin-derived melanocytes were generated as
described [51]. Briefly, skins from neonatal wild-type C57BL/6 or
Pmel
2/2 mice were digested with trypsin to separate the epidermis
from the dermis, and the epidermis (containing the melanocytes)
was further digested to a single cell suspension with trypsin and
seeded onto a feeder layer of XB2 keratinocytes. Cells were
cultured in RPMI 1640 (InVitrogen, Carlsbad, CA) supplemented
with 10% FBS, 200 nM TPA, and 2 nM cholera toxin in a
humidified incubator with 10% carbon dioxide. For analyses, cells
were cultured without feeders.
Immunoblotting—primary melanocytes
Cells were harvested with 5 mM EDTA in PBS, lysed with
0.5% SDS, 1% 2ME, and boiled to obtain whole cell lysates.
Lysates corresponding to equivalent numbers of cells were
fractionated by SDS-PAGE using Tris-glycine gels and then
transferred to PVDF membranes (Millipore) for immunoblotting
analysis as described [21,50]. Protein bands were detected with
alkaline phosphatase conjugated secondary antibodies, enhanced
chemifluorescence, and phosphorimaging analysis using a Storm
860 fluorescence imaging system and ImageQUANT software
(GE Biosciences).
Immunoblotting—sclera
Eyes were collected from wild-type and Pmel
2/2 mice. The
pigmented sclera was isolated by dissection and homogenized
using a Tissue Tearor in lysis buffer (20mM Tris, 0.1% Triton,
0.1% SDS, 50mM NaCl and 2.5mM EDTA, 1nM Na3VO4 and
1X protease inhibitor cocktail (Roche)). 25mg of total protein
lysates were denatured in sample buffer and reducing agent. The
samples were separated on a bistris 8–12% gel (Invitrogen).
Proteins were transferred to a hybond-C extra membrane
(Amersham Biosciences). Unspecific binding to the membrane
was blocked using 5% skimmed milk in TBS 0.1% Tween.
Primary aPep13h or actin (Santa Cruz Biotechnology) antibody
was added in blocking buffer in a 1:1000 dilution O/N. The
membranes were washed in TBS 0.1% Tween and HRP
conjugated anti rabbit (GE Healthcare) or anti goat secondary
(DAKO) antibodies in a 1:4000 dilution. The membranes were
subsequently washed in TBS 0.1% Tween and developed using
ECL plus (GE Healthcare).
Immunofluorescence and bright-field microscopy
Primary melanocytes were grown on matrigel-coated coverslips,
fixed with 2% formaldehyde, labeled with primary and fluoro-
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analyzed on a DM IRBE microscope (Leica Microsystems,
Wetzlar, Germany) equipped with an Orca digital camera
(Hamamatsu, Bridgewater, NJ). Images were captured and
manipulated using OpenLab software (Improvision, Lexington,
MA) as described [52], and processed using Adobe Photoshop
software.
Electron microscopy
Primary melanocyte cultures were fixed in a mixture of 4%
paraformaldehyde and 2% glutaraldehyde in cacodylate buffer
pH 7.4, post fixed with 2% Osmium tetroxide harvested by
scraping, dehydrated in ethanol, and embedded in epon resin.
Ultrathin sections were contrasted with 2% uranyl acetate,
analyzed by transmission electron microscopy on a Philips
CM120 electron microscope (FEI, Eindoven, The Netherlands),
and digital acquisitions were made with a numeric camera Keen
View (Soft Imaging System, Munster, Germany). Individual
melanosomes within electron micrographs of epon-embedded
sections were identified and the maximum width and height of
each melanosome was measured using OpenLab software. At least
200 melanosomes were counted for each cell type. Statistical
analyses were done using Microsoft Excel linear regression analysis
to determine the correlation coefficient between melanosome
width and length.
Electron microscopy analysis of stria vascularis of the inner ear
cochlea was done as follows. The mice were deeply anaesthetized
with pentobarbital and transcardially perfused with 0.9% saline
followed by fixative containing 2.5% glutaraldehyde and 0.5%
paraformaldehyde in a phosphate buffer pH 7.2. After the animals
were decapitated, their temporal bones were removed and their
cochleas were dissected out. Local perfusion was carried out with
the same fixative and the cochleas were left in the solution over
night at +4
oC. The cochleae were decalcified in 0.1 M EDTA for
approximately one week until the bone was soft. Rinsing with
phosphate buffer was performed several times followed by post
fixation in 1% osmium tetroxide. The tissues were dehydrated and
embedded in Agar 100 (Agar 100 Resin kit, Agar Scientific
Limited). To orient the tissue, 1 mm thick sections were made on
an ultratome (LKB Cryo Nova), stained with toluidine blue and
investigated in a light microscope. The stria vascularis at the lower
apical turn of the cochlea were chosen and ultra-thin sections were
cut in this area, mounted on formvar coated copper grids, stained
with uranyl acetate and lead citrate to be examined with a
transmission electron microscope (JEOL 1230).
In the perfused animals the entire eyes were extirpated and
transported to the morphology laboratory in the same fixative as
the previous perfusion. The anterior segment of the eyes from each
animal was discarded leaving posterior eyecups used for the light-
and electron microscopic studies. Eyecups were incubated with
gentle agitation in the same fixative for at least 2 h at room
temperature. The full length of each eyecup was then gross
sectioned with two vertical sections through the optic nerve head
and 2 mm temporally. Samples were post-fixed in 1% osmium
tetroxide and embedded in epoxy resin. They were washed with
0.17M sodium cacodylate, pH 7.4, followed by secondary fixation
in 1% osmium tetroxide. Subsequently, the samples were
dehydrated via sequential incubation in increasing concentrations
of acetone and embedded in epoxy resin. Sections of the
embedded samples were cut for both LM and EM examinations.
For LM, 1 mm thick sections were mounted on glass slides and
were stained with Toluidine blue. For EM, sections were mounted
on copper grids and were stained with uranyl acetate and lead
citrate. Light microscopy was performed using a Zeiss Axiophot
microscope in order to choose areas of interest for the EM studies.
The electron microscopy was performed using a JEOL 1200 EX
transmission electron microscope.
Electroretinography (ERG)
Two knockout mice (one male, one female, aged 23 months)
and two age-matched mice were used for the experiment. The
experiments were approved by the regional Ethical Committee
and carried out following the guidelines of the ARVO guidelines
for animal experimentation.
The ERGs were recorded under general anaesthesia induced by
intraperitoneal injection of 3 mg/kg acepromazine (Plegicil vet
10 mg/ml, Pharmaxim Sweden AB, Alcon, Sweden), 100 mg/kg
ketamine (Ketaminol vet 50 mg/ml, Intervet AB, Sollentuna,
Sweden) and 20 mg/kg xylazine (Narcoxyl vet 20 mg/ml, Intervet
AB, Sollentuna, Sweden).
The mice were placed in sternal recumbency. The ERGs were
recorded using corneal electrodes (Goldring, 3 mm, Roland
Consult, Brandenburg, Germany) with isotonic eye drops
containing 0.2% hyaluronic acid (ZilkEye, Evolan Pharma AB,
Danderyd, Sweden) as coupling agent. Subcutaneous platinum-
iridium needle electrodes served as ground and reference
electrodes (Technomed Subdermal EEG Needle Electrodes,
Cephalon A/S, Nørresundby, Denmark).
Light stimulation was generated by a xenon strobe (Grass
PS33+, Astro-Med Inc, West Warwick, RI, USA) and a diffuser on
the inner surface of a Ganzfeld dome spread light. Neutral density
filters (Kodak Wratten no. 96, Kodak Rochester, NY, USA) were
used to decrease the stimulus intensity. Light intensity was
measured by a light meter (IL-1700, International Lights,
Peabody, MA, USA) at level with the tested eye in the Ganzfeld.
Responses were amplified and filtered by a bandpass filter (0.1–
1,000 Hz) and stored using a Powerlab system (Powerlab, SP8,
ADInstruments (Europe) LTD, Chalgrove, UK).
The mice were dark-adapted overnight and anesthetized and
prepared for ERG under dim red light. A heating pad was used
to maintain the body temperature throughout the ERG. Dark-
adapted responses were recorded over a 4.5 log unit range up to
3.0 cd/m
2/s, starting with the dimmest stimulus. Four responses
presented at a frequency of 0.05 Hz were averaged to each
stimulus intensity. Cone responses were recorded after light
adaptation in the Ganzfeld with a steady, white background
light (25 cd/m
2) for 10 min. Averaged cone transient responses
were obtained in response to 3.0 cd/m
2/s flashes presented at
1.1 Hz and finally a light adapted, 30 Hz, cone flicker response
was recorded. Amplitudes and implicit times were determined
for each response and measured according to convention.
Three-generation intercross
Two Pmel
2/2 males (backcrossed four generations to C57BL/
6 background) were intercrossed with ten BALB/C females to
generate F1 offspring heterozygous at the A (Agouti), B (Tyrp1), C
(Tyrosinase) and Pmel loci. Subsequently, ten F1 males and 20 F1
females were intercrossed to generate 147 F2 offspring, with
segregating genotypes at the four loci. SNP markers were
developed for the Asip (rs27342000), Tyrp1 (rs32544046) and Tyr
(rs31392322) loci (Table S2). The C57BL/6 (Pmel
2/2) and
BALB/C mice were fixed for different alleles at these SNP
positions. The F2 offspring were genotyped at the four loci
using pyrosequencing (Biotage, Uppsala, Sweden). Oligonucle-
otides are listed in Table S1. The coat and skin color of the
mice in the F2 generation were ocularly examined at four weeks
of age.
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Dorsal hairs of four-week-old mice were plucked and processed
for chemical analysis of eumelanin to detect the specific
degradation product, pyrrole-2,3,5-tricarboxylic acid (PTCA)
upon alkaline hydrogen peroxide oxidation [33], and of
pheomelanin to detect the specific degradation product, 4-
amino-3-hydroxyphenylalanine (4-AHP) upon hydroiodic acid
hydrolysis [36], as reported previously. Content of total melanin
was determined as absorbance at 500 nm (A500) after solubilizing
1 mg hair in 900 mL Soluene-350 plus 100 mL water as previously
described [34].
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Supporting Information
Figure S1 Western blot analysis of the RPE and choroid layer
lysates of Pmel
2/2 and wild-type mice. The lysates were
fractionated by SDS-PAGE and analyzed by immunoblotting
using the Pep13h antibody. Actin was used as a loading control.
PMEL protein was detected in the wild-type lysate but not in the
Pmel
2/2 lysate.
(TIF)
Figure S2 Sections of cochleas, dissected from the inner ear of
Pmel
2/2 and wild-type mice, observed by electron microscopy. All
cells, including the intermediate cells harboring the pigment are
represented. The pigmentation was similar in the Pmel
2/2 samples
(c–f ) compared to wild-type (a–b).
(TIF)
Table S1 Amino acid identity between the mouse PMEL
protein and PMEL proteins in other vertebrates (data from
HomoloGene entry 5048, www.ncbi.nlm.nih.gov).
(DOCX)
Table S2 Oligonucleotides used for PCR and pyrosequencing
analysis of the Pmel locus in mice. All three forward oligonucle-
otides used for pyrosequencing have an M13-tag sequence,
allowing the M13-Biotin labeled oligonucleotide to anneal.
(DOCX)
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